Prous Institute invests in FollowApp.Care, the AI driven patient-centric communication platform

Prous Institute invests in FollowApp.Care, the AI driven patient-centric communication platform

Follow-app care uses population level insights on behaviour and communication patterns to drive up patient experience and engagement.

London, England and Barcelona, Spain – January 25, 2023

Prous Institute has signed an investment agreement in Follow-App.Care. Proceedings will be used to reinforce product development efforts and global commercial and partnership alliances.

Follow-App.Care technology helps healthcare providers to deliver successful patient outcomes and increase satisfaction and loyalty while boosting revenue and operational efficiency. The platform allows to analyze key outcome information to enable both providers and researchers to understand patient behaviour, so they can keep improving the quality of care patients receive.

Follow.App care is led by a seasoned management team including its CEO & Founder Dr. David Holmes. The company’s technology has been adopted by leading global healthcare providers

The company is targeting a Series A funding round in 2024


About Prous Institute for Biomedical Research

Prous Institute for Biomedical Research, created as a spin-off of Prous Science (acquired by

Thomson Reuters, now Clarivate Analytics, in 2007) is committed to supporting the discovery of novel therapeutic and diagnostic approaches. Originally founded by Dr. J.R. Prous, Prous Institute has evolved to expand its mission beyond its own developments by partnering and investing in transformative science initiatives. By leveraging more than 60 years’ experience in the life sciences, we offer the resources and capabilities needed by researchers to move their research closer to the patient bedside.

Learn more at


About FollowApp.Care

Our enthusiastic and dedicated team share one passion: to help healthcare providers deliver better and more personal care to patients inside and outside of the clinic. We believe that the best medicine meets the unique needs of each patient, and so we develop technologies that enable healthcare providers to deliver increasingly personalised care at scale and at reduced cost. Our mission is to help our healthcare providers improve their revenue growth, operational efficiency and the care their patients receive through intuitive patient pathways and the latest breakthroughs in artificial intelligence.

FollowApp is ISO 27001 certified and our technology is GDPR and HIPAA compliant, has been validated by the American National Institutes of Health and is widely used by leaders in the private healthcare delivery worldwide.

Learn more at